Matthew Kelsey
Stock Analyst at HC Wainwright & Co.
(0.13)
# 4,332
Out of 4,975 analysts
7
Total ratings
25%
Success rate
-28.84%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Kelsey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNSE Sensei Biotherapeutics | Assumes: Buy | $100 | $8.32 | +1,101.92% | 1 | Jun 2, 2025 | |
| ACXP Acurx Pharmaceuticals | Assumes: Buy | $160 | $4.08 | +3,821.57% | 1 | May 15, 2025 | |
| DBVT DBV Technologies | Maintains: Equal-Weight | $260 → $100 | $8.97 | +1,015.32% | 5 | Dec 20, 2018 |
Sensei Biotherapeutics
Jun 2, 2025
Assumes: Buy
Price Target: $100
Current: $8.32
Upside: +1,101.92%
Acurx Pharmaceuticals
May 15, 2025
Assumes: Buy
Price Target: $160
Current: $4.08
Upside: +3,821.57%
DBV Technologies
Dec 20, 2018
Maintains: Equal-Weight
Price Target: $260 → $100
Current: $8.97
Upside: +1,015.32%